Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-22 6:07 pm Purchase | 2022-12-12 | 13G | Adicet Bio, Inc. ACET | EcoR1 Capital, LLC | 3,560,700 8.300% | 3,560,700 (New Position) | Filing History |
| 2022-11-23 12:28 pm Purchase | 2022-11-14 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital, LLC | 5,232,279 5.500% | 5,232,279 (New Position) | Filing History |
| 2022-11-18 1:40 pm Purchase | 2022-11-11 | 13G | Graphite Bio, Inc. GRPH | EcoR1 Capital, LLC | 816,014 9.800% | 816,014 (New Position) | Filing History |
| 2022-11-14 4:56 pm Purchase | 2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO | EcoR1 Capital, LLC | 1,785,663 9.990% | 1,785,663 (New Position) | Filing History |
| 2022-11-01 4:01 pm Purchase | 2022-10-31 | 13G | Zymeworks Inc. ZYME | EcoR1 Capital, LLC | 7,568,573 12.000% | 1,600,000 (+26.81%) | Filing History |
| 2022-10-28 5:34 pm Purchase | 2022-10-18 | 13G | NGM Biopharmaceuticals, Inc. NGM | EcoR1 Capital, LLC | 6,435,518 8.000% | 6,435,518 (New Position) | Filing History |
| 2022-10-28 5:33 pm Purchase | 2022-10-26 | 13G | Zymeworks Inc. ZYME | EcoR1 Capital, LLC | 5,968,573 9.900% | 5,968,573 (New Position) | Filing History |
| 2022-09-26 4:06 pm Purchase | 2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX | EcoR1 Capital, LLC | 3,493,194 5.500% | 3,493,194 (New Position) | Filing History |
| 2022-09-19 08:27 am Purchase | 2022-09-07 | 13G | SpringWorks Therapeutics, Inc. SWTX | EcoR1 Capital, LLC | 3,460,208 5.500% | 3,460,208 (New Position) | Filing History |
| 2022-06-27 4:33 pm Purchase | 2022-06-16 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital, LLC | 4,278,069 5.800% | 4,278,069 (New Position) | Filing History |
| 2022-05-16 4:08 pm Purchase | 2022-05-06 | 13G | Arvinas, Inc. ARVN | EcoR1 Capital, LLC | 3,123,300 5.900% | 3,123,300 (New Position) | Filing History |
| 2022-04-26 12:58 pm Purchase | 2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital, LLC | 4,276,507 11.100% | 719,000 (+20.21%) | Filing History |
| 2022-04-11 4:26 pm Purchase | 2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 1,975,611 6.300% | 1,975,611 (New Position) | Filing History |
| 2022-04-07 6:23 pm Purchase | 2022-03-02 | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital, LLC | 509,086 9.990% | 509,086 (New Position) | Filing History |
| 2022-03-14 3:55 pm Purchase | 2022-03-11 | 13G | Surface Oncology, Inc. SURF | EcoR1 Capital, LLC | 4,653,000 9.900% | 4,604,442 (+9482.36%) | Filing History |
| 2022-02-14 4:55 pm Purchase | 2022-02-04 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 128,532 7.500% | 128,532 (New Position) | Filing History |
| 2022-02-14 4:02 pm Purchase | 2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 5,523,358 7.900% | 951,311 (+20.81%) | Filing History |
| 2022-02-14 4:01 pm Unchanged | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital, LLC | 3,557,507 9.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:58 pm Purchase | 2021-12-31 | 13G | 2seventy bio, Inc. TSVT | EcoR1 Capital, LLC | 1,917,063 8.200% | 26,400 (+1.40%) | Filing History |
| 2022-02-14 3:22 pm Sale | 2021-12-31 | 13G | Shattuck Labs, Inc. STTK | EcoR1 Capital, LLC | 0 0.000% | -3,295,088 (Position Closed) | Filing History |